Analysis: Warsh rate hike reinforces Fed independence after Trump pressure Americans' incomes rose and poverty fell in 2025, Census Bureau says OpenAI CFO Sarah Friar emphasizes 'need to take safety seriously' on AI risks Elon Musk, the world’s richest man, says he’s living in an Airstream trailer to oversee xAI’s biggest expansion yet Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns

Stéphane Bancel

Stéphane Bancel

Stéphane Bancel (#825)

Global Rank #825
Country Rank #23
Country France

Stéphane Bancel is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 5 B
  • Biotech, vaccines
  • France
  • M
  • 54 Years

Snapshot

Quick Facts

Global Rank #825
Country Rank #23
Net Worth $5.2B
Previous Worth $4.8B
Worth Change +$0.4B
Country France
Industry Biotech, vaccines
Age 54 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 14 Sep 2026, 12:00 AM
Residence Boston, Massachusetts
World Billionaires List France Billionaires Biotech, vaccines

Profile Data

Personal Stats

Age 54
Source Of Wealth Biotech, vaccines, Self Made
Residence Boston, Massachusetts
Citizenship France
Marital Status Married
Children 2
Education Master of Business Administration, Harvard University; Master of Science in Engineering, Ecole Centrale Paris; Master of Science in Engineering, University of Minnesota
Net Worth Change +$0.4B +8.3% from previous worth
Previous Net Worth $4.8B
Current Net Worth $5.2B

Worth as of May 4, 2026

About Me

Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine. He became CEO of Moderna in 2011 and owns a roughly 5.5% stake in the publicly traded company. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMerieux, founded by fellow French billionaire Alain Merieux. Moderna's Covid-19 vaccine was granted full FDA approval in January 2022; it had previously received emergency-use authorization in December 2020. Moderna was founded in 2010 and went public in December 2018; the company develops drugs and vaccines using messenger RNA.

Wealth Growth

Net Worth Growth Over Time

Tracking Stéphane Bancel's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $5.2B (May 4, 2026)

© Iconic Billionaires